INTRODUCTION
Chronic periodontitis is linked to the presence of a subgingival microbial biofilm that stimulates persistent inflammation of the marginal gingiva and is characterized by the destruction of the periodontium, resorption of alveolar bone and subsequent loss of teeth (Oliver & Brown, 1993; Oliver et al., 1998) . This subgingival biofilm is a consortium of microbial species that includes the gram-negative, anaerobic bacterium Porphyromonas gingivalis (Socransky et al., 1998; Tran & Rudney, 1999; Lamont & Jenkinson, 2000) . Severe periodontitis and periodontal disease progression have been associated with P. gingivalis colonization of the oral mucosa and gingival sulcus (Yang et al., 2004; Byrne et al., 2009) . Therapeutic interventions that reduce the burden of P. gingivalis in patients suffering from periodontitis result in restoration of gingival health, but without a concomitant regeneration of the destroyed periodontium (Van Dyke et al., 1988) .
Bacterial colonization of the gingival sulcus and organization of the bacterial plaque biofilm induce an initial robust innate immune response that primarily involves recruitment and transepithelial migration of neutrophils and a strong inflammatory response characterized by secretion of pro-inflammatory cytokines such as interleukin-6 (IL-6), tumor necrosis factor-a and interferon-c (IFN-c) (Dixon et al., 2004) . Adaptive immune responses through activated CD4 + T helper cells and secretion of immunoglobulin by B cells also play a part in containment of the biofilm but, paradoxically, may also be drivers of disease progression (Baker et al., 1999 (Baker et al., , 2002 . In a murine model of periodontitis, adaptive immune responses, primarily through effector CD4 + T helper cells, were found to contribute extensively to P. gingivalis-induced alveolar bone loss (Baker et al., 1999 (Baker et al., , 2002 . The role that different CD4 + T helper cell subsets play in the pathogenesis of periodontal diseases remains unresolved (Gemmell et al., 2007) . Significant levels of P. gingivalis-specific immunoglobulins have been found in the sera of patients with ongoing periodontal disease (Ebersole et al., 1987) . The antibody response and effector function of the immunoglobulin molecule are preceded by CD4 + T helper cell differentiation. Therefore, the pro-inflammatory effector functions of isotype-switched immunoglobulins via complement activation and opsonization of the oral biofilm are essentially a result of the CD4 + T helper cell phenotype. In patients with active periodontitis, it is unclear if effector CD4 + T helper cells ensure disease protection via macrophage activation/ neutrophil recruitment and antibody-mediated immunity or whether such a heightened immune response drives osteoclastogenesis and, consequently, periodontal destruction (Gemmell et al., 2007) . Despite a number of reports that describe the identification of B-cell epitopes within important P. gingivalis virulence factors (O'Brien-Simpson et al., 2005; Frazer et al., 2006; Miyachi et al., 2007; Sharma et al., 2007) , the nature of the specific protective CD4 + T-cell response against such proteins remains unknown in humans and is poorly understood in mice (Tam et al., 2008) . Bridging this gap in our knowledge is critical to our understanding of the pathogenesis of periodontitis and to the development of an effective protein-based vaccine against P. gingivalis. In this current work, we choose C57BL/6 mice to screen P. gingivalis proteins for immunodominant CD4 + T-cell epitopes. The C57BL/6 strain is well characterized as a murine model of periodontitis (Baker et al., 2000a) (Moon et al., 2007 (Moon et al., , 2009 ).
We targeted P. gingivalis gingipains and two highly expressed outer membrane proteins of the OmpA superfamily that are highly conserved and that are potentially immunogenic in mice (Ross et al., 2004) . Gingipains are arginine-or lysine-specific cysteine proteinases that are implicated in the proteolytic breakdown of immunoglobulins, matrix proteins and surface receptors found on cells resident in the gingiva, the degradation and inactivation of inflammatory cytokines, and have been associated with disease progression and periodontal bone destruction in animal models of periodontitis (O'Brien-Simpson et al., 2003) . We hypothesize that I-A b -binding peptides existing in Kgp and RgpA are presented to CD4 + T cells during P. gingivalis oral colonization. Furthermore, we predict that such epitopes will allow us to construct pMHCII tetramers that can be used as a tool to track and phenotype specific CD4 + T cells activated after oral infection with P. gingivalis.
METHODS
Mice C57BL/6J mice (H-2 b ) were purchased from The Jackson Laboratory (Bar Harbor, ME) and housed in microisolator cages in accordance with University of Minnesota and National Institutes of Health guidelines. All experiments were performed on agematched (6-8 weeks) and sex-matched mice using protocols approved by the Institutional Animal Care and Use Committee of the University of Minnesota.
In silico identification of potential immunodominant peptides
The amino acid (aa) sequence of cysteine proteinase gingipains RgpA (PGN_1970, 1703 aa) and Kgp (PGN_1728, 1723 aa), and putative outer membrane proteins OMP40 (PGN_0728, 380 aa) and OMP41 (PGN_0729, 391 aa), were retrieved from the NCBI database containing the complete annotated sequence of P. gingivalis strain ATCC 33277 (Naito et al., 2008) . Each protein sequence was scanned using the Wilson-Rudensky (W-R) scoring matrix (Zhu et al., 2003) to identify 9-mer peptides with the potential to fit the peptide-binding groove of the murine MHC class II I-A b molecule. Peptides that had an aggregate score of 50 or more were synthesized (GenScript, Piscataway, NJ) and their ability to invoke CD4 + T-cell responses in ELISpot experiments was determined.
Mice inoculations
Mice were injected subcutaneously at three points along each flank with a total of 3 9 10 9 colonyforming units (CFU) of live P. gingivalis strains ATCC 53977, W50 or DPG3 prepared in de-gassed phosphate-buffered saline (PBS), sham inoculated with a similar volume of PBS, or injected with 25 lg lipopolysaccharide in incomplete Freund's adjuvant with or without (vehicle control) pooled peptide. These strains were chosen for their ability to induce alveolar bone loss in a murine model of periodontitis (Baker et al., 2000a) . Peptide pools resuspended in dimethyl sulfoxide and emulsified, contained 100 lg of each constituent peptide. Mice were sacrificed 14 days after inoculation and lymph nodes draining the subcutaneous injection sites and spleens were harvested for ELISpot. In subcutaneous immunization experiments, mice were re-challenged with live P. gingivalis 10 days after the primary inoculation so as to boost CD4 + T-cell responses. In experiments requiring oral infection, mice were pre-treated with antibiotics and fed 4 9 10 9 CFU P. gingivalis in 2% carboxymethylcellulose or vehicle control by oral gavage, six times, 4 days apart as previously described (Baker et al., 1999) . Blood was drawn on day 12 to check for immunoglobulins specific against P. gingivalis using ELISA and paper-point samples were taken from the oral cavity and plated on sheep blood agar plates to confirm P. gingivalis colonization. Mice were sacrificed 14 days after their last oral feed and draining cervical lymph nodes were harvested for detection of antigen-specific CD4 + T cells.
ELISpot
Single-cell preparations from lymph nodes and spleens of control or inoculated mice were prepared and CD4 + T cells were purified by negative selection using magnetic cell sorting according to the manufacturer's recommended protocol (Miltenyi Biotec, Auburn, CA). We routinely found CD4 + T cells as ), or 1 9 10 8 CFU of P. gingivalis strains ATCC 53977, W50 and DPG3. All microorganisms had been killed by freezing in O 2 -saturated PBS. ELISpot plates were incubated at 37°C, 5% ambient CO 2 , for 46 h in a humidified incubator then each well was washed five times with 200 ll wash buffer [1 9 Dulbecco's phosphate-buffered saline (DPBS), 0.05% Tween-20] followed by two rinses with Milli-Q water. For ELISpot plate development, plates were incubated with biotinylated anti-IFN-c or IL-17A detection antibodies (eBioscience) (50 ng in 100 ll 1 9 DPBS, 10% fetal bovine serum per well) at room temperature for 3 h, washed six times with 200 ll wash buffer, twice with 200 ll 1 9 DPBS then incubated with streptavidin-conjugated horseradish peroxidase (eBioscience) (100 ll of a 1/1000 dilution in 1 9 DPBS, 10% fetal bovine serum) for 45 min protected from light. Wells were washed four times with 200 ll wash buffer and 2 9 with 200 ll 1 9 DPBS. Finally, cytokine-positive cells were revealed as discrete spots following incubation with 100 ll 3-amino-9-ethylcarbazole substrate solution (BD Biosciences, San Jose, CA) at room temperature for 20 min and enumerated using IMMUNO-SPOT software coupled to an ELISpot plate reader (Cellular Technology Limited, Cleveland, OH). Onetailed Student's t-test was used to determine statistical significance between sample means. were stained with 25 nM of pR/Kgp:I-A b tetramer as described above followed by incubation with 50 ll of anti-PE-conjugated magnetic microbeads (Miltenyi Biotec) as described by Moon et al. (2009) . The pR/Kgp:I-A b tetramer stained cells were enriched using Miltenyi LS columns mounted in a MidiMACS magnet apparatus, surfaced stained, prepared for flow cytometry and analysed using FLOWJO software as described above.
RESULTS

Selection of suitable proteins from P. gingivalis
To increase the likelihood of identifying immunodominant CD4 + T-cell epitopes derived from P. gingivalis, we chose to work with P. gingivalis proteins that are abundantly expressed and that are anchored within the membrane and/or are secreted. We selected two well-characterized virulence factors, lysine-gingipain (Kgp 1723 aa; Accession no. BAG34247) and arginine-gingipain A (RgpA 1703 aa; Accession no. BAG34488), and two outer membrane proteins (OMP40 380 aa; Accession no. AAD51068.1 and OMP41 391 aa; Accession no. AAD51067.1) that fit these criteria. These proteins also have the advantage of being highly conserved across a number of sequenced P. gingivalis strains (O'Brien-Simpson et al., 2003; Ross et al., 2004) , including those considered to be most virulent in a murine model of periodontitis (Baker et al., 2000b) . Furthermore, the high degree of homology between RgpA and Kgp has the additional benefit of allowing us to identify potential CD4 + T-cell epitopes that are shared between these two important virulence factors.
Relatively few peptides are predicted to fit the I-A b peptide-binding groove with high affinity
We used an I-A b peptide-fitting algorithm (W-R) to identify potentially immunodominant CD4 + T-cell epitopes (Zhu et al., 2003) . The W-R algorithm analyses the sequence of a protein in blocks of nine amino acids using a sliding window of one and assigns an aggregate score to the 9-mer peptides based on the probability of a particular amino acid occupying the anchoring pockets of the I-A b molecular groove at positions P1, P4, P6, P7 and P9. Amino acids at positions P2, P3, P5 and P8 were not scored because at these positions they would be oriented away from the I-A b molecular groove and toward the T-cell receptor. For example, Kgp was scored for 1715 possible 9-mer peptides with most of them not meeting the cutoff criteria of a W-R score of at least 50 (see below). Given that most peptides eluted from I-A b are longer than nine amino acids (Dongre et al., 2001) , we chose to extend each candidate peptide by adding the two preceding amino acids to the N-terminal end. We predicted that these longer peptides would be more likely to be displayed by the I-A b molecule as immunogenic peptides in our ELISpot assays. However, one consequence is that each 11-mer now has three potential fitting registers within the I-A b peptide-binding groove. One register defined by the W-R score beginning at P1, and two others beginning at positions -P1 and -P2. Any 11-mer peptides that had alternative I-A b binding registries with W-R score greater than 40 were not synthesized because the generation of a unique pMHCII tetramer would not be guaranteed. The amino acid sequence, relative sequence position and W-R score assigned to each candidate peptide are provided in Table 1 . Our stringent selection criteria gave us a total of 53 peptides divided between Kgp (14 peptides), RgpA (15 peptides), shared Kgp/RgpA (13 peptides), OMP40 (six peptides) and OMP41 (five peptides) that were subsequently synthesized and used to immunize C57BL/6 mice expressing the I-A b molecule on APCs (Fig. 1B) . Peptides that passed both of the inclusion criteria were synthesized and numbered 1 through 53.
Inclusion criteria for 11-mers
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set of six peptides with W-R score > 60, including peptide 13 (see below). Therefore, C57BL/6 mice were subcutaneously immunized with sets of nine different pooled peptides plus E. coli lipopolysaccharide in incomplete Freund's adjuvant. The objective was to test whether the peptides identified with the W-R algorithm were able to stimulate the CD4 + T-cell repertoire of C57BL/6 mice, which could be re-stimulated in vitro with P. gingivalis. Purified CD4 + T cells were incubated with either irradiated naive splenocytes plus peptide sub-pools comprising three constituent peptides or P. gingivalis. We observed that P. gingivalis induced IFN-c and IL-17A expression in effector/memory CD4 + T-cell clones primed with Kgp peptides 1 to 9 ( Fig. 2A,B) or primed with RgpA/Kgp shared peptides 10 to 18 (Fig. 2C,D) . Peptides 19 to 27, which are found in both RgpA and Kgp, primed effector/memory CD4 + T cells that when re-stimulated with P. gingivalis or peptide sub-pool comprising peptides 22 to 24 expressed primarily IFN-c (Fig. 2F ), but not IL-17A (Fig. 2E) . Peptides 28 to 36 were not considered immunogenic because only a weak response was seen when CD4 + T cells from immunized mice were re-stimulated in the presence of P. gingivalis or subpool peptides (Fig. 2G,H) . Pooled peptides from OMP40 and OMP41 (peptides 46-53) were very efficient in priming a set of effector/memory CD4 + T cells specific for peptides 49-51. These cells expressed either IFN-c or IL-17A. However, such subsets of effector/memory CD4 + T-cell specificities could not be re-stimulated by P. gingivalis (Fig. 2K,L) . Further examination of peptides 49, 50 and 51 demonstrated that the epitope in peptide 51, despite being highly immunogenic, falls within the putative signal peptide of OMP41 (data not shown). It is highly likely that this epitope is removed during OMP41 maturation and may not be available for loading onto MHC class II molecules during processing of P. gingivalis by APCs. Therefore, notwithstanding the extremely efficient priming and re-activation of effector/ memory CD4 + T cells, peptide 51 was not suitable for incorporating into a pMHCII tetramer. Similarly, one or more of peptides 37, 38 or 39 was found to be immunogenic when CD4 + T cells from immunized mice were re-stimulated with this sub-pool, but not when re-stimulated with P. gingivalis (Fig. 2I,J) .
Porphyromonas gingivalis re-stimulates CD4 + T cells when initially primed with peptide 7 (pKgp) and peptide 13 (pR/Kgp)
We found three peptide sub-pools that induced the priming of CD4 + T cells, which could be re-stimulated by P. gingivalis in ELISpot assays. To reveal the identities of the single immunodominant CD4 + T-cell epitope responsible, we immunized C57BL/6 mice with the appropriate three-peptide sub-pools (7-9; 13-15; 22-24) . When C57BL/6 mice were primed subcutaneously with pooled peptides 7-9, more effector/memory CD4 + T cells released IFN-c and IL-17A
when re-stimulated with individual peptide 7 (Kgp 467-477 ; DKYFLAIGNCC) than with peptide 8 or 9 (Fig. 3A,C) . This demonstrates that peptide 7 from Kgp is the dominant immunogenic component of the 7-9 peptide sub-pool. Interestingly, peptide 9 was also able to re-stimulate effector/memory CD4 + T cells to release IFN-c and IL-17A, but the magnitude of the response was less than that seen with peptide 7. Peptides 13-15 primed effector/memory CD4 + T cells to release IFN-c when re-stimulated with peptide 13 (RgpA 1054-1064 /Kgp 1074-1084 ; AVYASSTGN DA) but not with peptides 14 or 15 (Fig. 3B ). This determines that peptide 13 found in both Kgp and RgpA is the immunogenic component of the 13-15 peptide subpool. Moreover, P. gingivalis was able to re-stimulate peptide 7-specific and peptide 13-specific effector/ memory CD4 + T cells to produce IFN-c confirming that both these peptides are displayed on I-A b molecules following P. gingivalis processing by APCs (Fig. 3A,B) . However, only peptide 7 induced IL-17A-producing effector/memory CD4 + T cells (Fig. 3C ).
Subcutaneous immunization with peptides 13-15 did not result in effector/memory CD4 + T cells capable of producing IL-17A when re-stimulated with peptide 13 alone or with P. gingivalis (Fig. 3D ). Peptides 22, 23 and 24 did not elicit effector/memory CD4 + T-cell responses above background when re-stimulated with individual peptide or P. gingivalis (data not shown). The response seen in Fig. 2F may be a result of the cumulative effect of individual weak responses by peptides 22, 23 and 24. RgpA/Kgp shared peptides 22, 23 and 24 were, therefore, deemed not to be suitable CD4 + T-cell epitopes for further study. In summary, these ELISpot results indicate that peptide 7 and peptide 13 are expressed by the P. gingivalis strains ATCC 53977, W50 or DPG3, are processed (Fig. 4D, open arrow) . The frequency of CD3 + CD4 + CD44 high pR/Kgp::I-A b + T cells in mice orally colonized with P. gingivalis was significantly higher than that found in sham-inoculated mice (Fig. 4F) , indicating significant clonal expansion. Furthermore, the very low frequency of CD8 + T cells stained by pR/Kgp::I-A b tetramer is indicative of its specificity for RgpA-and Kgp-specific CD4 + T cells (Fig. 4C,E) . As expected, very few naive pR/Kgp-specific CD4 + T cells (CD44 low ) were detected in samples prepared from the cervical lymph nodes of orally colonized or PBS-treated C57BL/6 mice (Fig. 4D,F) . In contrast, the specificity of the pKgp::I-A b tetramer (i.e. Kgp 467-477 peptide) was not sufficiently high to discriminate pKgp-specific CD4 + T cells from background staining of CD4 + T cells in general and of CD8 + T cells, and would not be a suitable reagent for future studies (data not shown).
DISCUSSION
We have taken a paired computational/ELISpot approach to reveal immunodominant CD4 + T-cell epitopes within important virulence factors of the periodontal pathogen P. gingivalis. Identification of immunodominant CD4 + T-cell epitopes is of particular interest in the development of vaccines that promote an effective cell-based immunity against particular pathogens. Moreover, the characterization of immunodominant CD4 + T-cell epitopes within known antigens can add valuable insight into the adaptive B-cell humoral response. We based our approach on the W-R algorithm that predicts the likelihood of a given peptide being displayed by the I-A b MHC class II molecule present in the C57BL/6 mouse (Zhu et al., 2003) . We found that relatively few peptides were able to trigger a CD4 + T-cell response as determined by ELISpot assays. Of the 53 peptides we selected based on an aggregate W-R score of greater than 50, only peptides 7, 9, 13, 51 and one of peptides 37, 38 or 39 were able to re-stimulate effector/memory CD4 + T cells in an antigen-specific manner when re-challenged with the matching individual peptides. The C57BL/6 mouse displays a unique MHC class II molecule, I-A b . Therefore, the repertoire of peptides that are capable of being presented is potentially narrower and less diverse compared with BALB/c mice (I-A Surprisingly, we did not find suitable CD4 + T-cell epitopes within the two outer membrane proteins that we examined even though members of the OmpA superfamily have been shown to be particularly immunogenic. OmpA proteins generate robust humoral responses in a number of infectious diseases (Weiser & Gotschlich, 1991; Das et al., 1998; Hara et al., 2009) . Ross et al. (2004) found that two soluble C-terminal fragments from OMP40 (213-380 aa) and OMP41 (224-391 aa) provided good protection against P. gingivalis infection when used as vaccines in a murine subcutaneous lesion model. Although none of our selected peptides fell within the OMP40 fragment tested, OMP41-derived peptides 44, 45, 46 and 48 all fall within the antigenic region identified by Ross et al. (2004) . Failure to detect these epitopes may be indicative of differences in MHC class II presentation of peptides between the BALB/c mice used by Ross et al. (2004) in their protection study and the C57BL/6 mice used here. Our inability to find such epitopes within OMP40 and OMP41 may be due to the characteristics of the I-A b groove compared with (Dongre et al., 2001; Zhu et al., 2003) . Alternatively, with the exception of peptide 51, the T-cell receptor specificities for OMP40 and OMP41 peptides were absent from the T-cell receptor repertoire of C57BL/6 mice. We may have also disregarded the other OMP40 and OMP41 CD4 + T-cell epitopes because of the stringent selection criteria that we put in place to avoid peptides having viable alternative I-A b binding registries. tested and peptide 13 (W-R score 72) ranked 4th overall. Both peptides scored well above our cutoff of 50. A high W-R score, however, does not necessarily translate into a peptide being an immunodominant CD4 + T-cell epitope. The W-R algorithm is based largely on displayed endogenous peptides and not those from pathogens. The mass spectrometry method used by Dongre et al. (2001) to identify these peptides may favour those of high relative abundance at the expense of those of lower abundance (Dongre et al., 2001; Zhu et al., 2003) . For example, the W-R algorithm assigns a high probability score of occupying the deep pocket at P1 to the relatively bulky hydrophobic amino acids phenylalanine (score 16) and tyrosine (score 30). Of our 53 selected peptides, 30 had either a tyrosine or a phenylalanine residue occupying P1, including both peptide 7 and 13, yet peptide 51 with an unfavoured leucine (score 4) at this position was very efficient in priming a set of effector/memory CD4 + T cells. Interestingly, peptide 51 had probably a larger population of responding effector/memory CD4 + T cells compared with either peptide 7 or 13, despite having a lower W-R score. Although stability of a peptide in the binding groove of an MHC class II molecule is important, the magnitude of the CD4 + T-cell response is also related to the frequency of the naive CD4 + T-cell population capable of recognizing a given epitope (Moon et al., 2007; Moon & Jenkins, 2012) . In this regard, the polyclonal population of peptide 7-or 13-specific naive CD4 + T cells that exists in C57BL/6 mice is probably smaller than that of peptide 51. Peptide 7 (Kgp 467-477 ; DKYFLAIGNCC) is located within the putative protease catalytic domain of Kgp and during P. gingivalis infection may act as an immunodominant CD4 + T-cell epitope providing T helper type 2 help to a B-cell-mediated humoral response to Kgp-derived antigen (Kuboniwa et al., 2001) . When used as a DNA vaccine in a lethal intraperitoneal mouse model, the catalytic domain of Kgp induced a response that prolonged survival rates by 43% following injection of live P. gingivalis (Kuboniwa et al., 2001) . The location of peptide 13 (RgpA 1054-
